体型参数与糖尿病患者10年心血管疾病风险和心脏年龄评分的关系

Relationship between body morphology parameters and ten-year cardiovascular risk and cardiac age score in diabetic patients

  • 摘要:
    目的 探讨体型参数体重指数(BMI)、腰围、体脂百分比、中国内脏脂肪指数(CVAI)与2型糖尿病患者10年心血管疾病风险、心脏年龄评分及理想水平血压率的关系。
    方法 纳入福建医科大学附属第一医院10 067例2型糖尿病患者进行横断面分析。按照Framingham 10年心血管疾病发病风险将患者分为低中风险组(风险≤20%)和高风险组(风险>20%)。通过Spearman相关性分析评估BMI、腰围、体脂百分比和CVAI与10年心血管疾病风险、心脏年龄评分及血压的线性关联;进一步使用限制性立方样条(RCS)分析(设置4个节点)确定各参数非线性拐点。
    结果 与低中风险组相比,高风险组患者的年龄更大、男性比例更高,BMI、腰围、CVAI、血压、三酰甘油及低密度脂蛋白胆固醇水平更高(均 P<0.001),其中BMI24.67 (22.57, 27.01) 比 23.88 (21.50, 26.31), Z = −10.71、腰围(89.42 ± 9.73 cm 比 85.17 ± 10.66 cm, t = −18.31)及CVAI(126.28 ± 39.66 比 99.07 ± 39.94, t = −29.02)。Spearman相关性分析表明,各体型参数均与10年心血管疾病风险及心脏年龄评分呈正相关(均 P < 0.001):BMI(r = 0.213;r = 0.160)、腰围(r = 0.235;r = 0.152)、体脂百分比(r = 0.113;r = 0.424)、CVAI(r = 0.351;r = 0.344)。RCS分析确定的拐点值为:BMI 24.35 kg/m2、腰围 87 cm、体脂百分比 29.2%、CVAI 115.06。低于拐点时,10年心血管疾病风险及心脏年龄评分随各体型参数增加而上升,理想水平血压率下降。以体型参数低于拐点定义为达标,logistic回归分析发现,体型参数达标数目与10年心血管疾病风险和心脏年龄呈剂量-反应关系,相较于单一参数管理,每增加1个达标参数,10年心血管疾病风险降低13.5%(OR=0.865,95%CI 0.829~0.902,P<0.001),高心脏年龄风险降低11.7%(OR=0.883,95%CI 0.835~0.933,P<0.001),理想水平血压率增加13.6%(OR=1.136,95%CI 1.101~1.172,P<0.001)。
    结论  综合管理多项体型参数可能显著降低糖尿病患者心血管疾病风险,为精准体重管理提供了循证依据。

     

    Abstract:
    Objective To investigate the relationships between body morphology parameters—including body mass index (BMI), waist circumference, body fat percentage, and the Chinese visceral adiposity index (CVAI)—and the 10-year cardiovascular disease (CVD) risk, cardiac age score, and rate of ideal blood pressure levels in patients with type 2 diabetes mellitus (T2DM).
    Methods A cross-sectional analysis was conducted involving 10,067 T2DM patients from The First Affiliated Hospital of Fujian Medical University. Patients were categorized into low-to-medium risk (risk ≤20%) and high-risk (risk >20%) groups based on the Framingham 10-year CVD risk score. Spearman correlation analysis was used to assess the linear associations of BMI, waist circumference, body fat percentage, and CVAI with the 10-year CVD risk, cardiac age score, and blood pressure. Restricted cubic spline (RCS) analysis with 4 knots was further employed to identify nonlinear inflection points for each parameter.
    Results Compared to the low-to-medium risk group, the high-risk group was older, had a higher proportion of males, and exhibited significantly higher levels of BMI, waist circumference, CVAI, blood pressure, triglycerides, and low-density lipoprotein cholesterol (all P<0.001). Specific examples included: BMI (24.67, IQR: 22.57 to 27.01 vs. 23.88 IQR: 21.50 to 26.31, Z = −10.71), waist circumference (89.42 ± 9.73 cm vs. 85.17 ± 10.66 cm, t = −18.31), and CVAI (126.28 ± 39.66 vs. 99.07 ± 39.94, t = − 29.02). Spearman correlation analysis revealed that all body morphology parameters were positively correlated with both the 10-year CVD risk and the cardiac age score (all P<0.001): BMI (r = 0.213; r = 0.160), waist circumference (r = 0.235; r = 0.152), body fat percentage (r = 0.113; r = 0.424), and CVAI (r = 0.351; r = 0.344). RCS analysis identified inflection points at BMI 24.35 kg/m2, waist circumference 87 cm, body fat percentage 29.2%, and CVAI 115.06. For values below these inflection points, the 10-year CVD risk and cardiac age score increased with rising parameter values, while the rate of ideal blood pressure levels decreased. Defining target achievement as having parameter values below these inflection points, logistic regression analysis demonstrated a dose-response relationship between the number of body morphology parameters meeting the targets and the outcomes. Each additional parameter meeting the target was associated with a 13.5% reduction in 10-year CVD risk (OR=0.865, 95% CI: 0.829 to 0.902, P<0.001), an 11.7% reduction in high cardiac age risk (OR=0.883, 95%CI: 0.835 to 0.933, P<0.001), and a 13.6% increase in the rate of ideal blood pressure levels (OR=1.136, 95%CI: 1.101 to 1.172, P<0.001).
    Conclusion Comprehensive management of multiple body morphology parameters may significantly reduce cardiovascular risk in diabetic patients, providing evidence-based support for precise weight management strategies.

     

/

返回文章
返回